13.4M XNAS Volume
XNAS 17 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| James Ziegler | EVP, Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 27 Feb 2025 | 100,000 | 100,000 (0%) | 0% | 1.6 | 160,000 | Common Stock |
| Scott Alan Samuels | EVP, Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 27 Feb 2025 | 15,000 | 26,682 (0%) | 0% | 1.6 | 24,150 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 27 Feb 2025 | 12,500 | 12,500 (0%) | 0% | 1.8 | 22,063 | Common Stock |
| James Ziegler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 89,000 | 89,000 | - | - | Restricted Stock Units | |
| James Ziegler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 529,000 | 529,000 | - | - | Stock Option (right to buy) | |
| Scott Alan Samuels | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 621,000 | 621,000 | - | - | Stock Option (right to buy) | |
| Scott Alan Samuels | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 104,000 | 104,000 | - | - | Restricted Stock Units | |
| Michelle Robertson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 656,000 | 656,000 | - | - | Stock Option (right to buy) | |
| Michelle Robertson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 110,000 | 110,000 | - | - | Restricted Stock Units | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 2,457,000 | 2,457,000 | - | - | Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 410,000 | 410,000 | - | - | Restricted Stock Units | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 839,000 | 839,000 | - | - | Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 140,000 | 140,000 | - | - | Restricted Stock Units | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 2,206 | 172,391 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,767 | 170,185 (0%) | 0% | 0 | Common Stock | |
| James Ziegler | EVP, Chief Commercial Officer | 09 Sep 2024 | 1,600,000 | 1,600,000 | - | - | Stock Option (right to buy) | ||
| Andrew J. Grethlein | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 08 Jul 2024 | 674,348 | 0 (0%) | 0% | 4.6 | 3,073,004 | Common Stock |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 221,544 | 0 | - | - | Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 452,804 | 0 | - | - | Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. | 08 Jul 2024 | 674,348 | 674,348 (0%) | 0% | 1.7 | 1,159,879 | Common Stock |
| Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 328,125 | - | - | Stock Option (right to buy) | ||
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Faye Feller | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 10 Jun 2024 | 287,900 | 0 (0%) | 0% | 4.6 | 1,334,129 | Common Stock |
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 112,500 | 87,500 | - | - | Stock Option (right to buy) | |
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 155,400 | 0 | - | - | Stock Option (right to buy) | |
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 10 Jun 2024 | 112,500 | 112,500 (0%) | 0% | 1.1 | 119,250 | Common Stock |
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 10 Jun 2024 | 20,000 | 20,000 (0%) | 0% | 1.1 | 21,200 | Common Stock |
| Faye Feller | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.30 per share. | 10 Jun 2024 | 155,400 | 155,400 (0%) | 0% | 1.3 | 201,243 | Common Stock |
| Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 421,875 (0%) | 0% | 1.1 | 447,188 | Common Stock | |
| Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 0 (0%) | 0% | 4.6 | 1,959,609 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 452,804 | 452,804 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
| Anil Kapur | EVP, Corp Strategy & CCO | 06 Jun 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Michelle Robertson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (Right to Buy) | |
| Faye Feller | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Faye Feller | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Scott Alan Samuels | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 2.5 | 1,524,000 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 600,000 | 0 | - | - | Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 04 Jun 2024 | 600,000 | 600,000 (0%) | 0% | 4 | 2,400,000 | Common Stock |
| V. Bryan Lawlis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | Director | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 15 May 2024 | 35,000 | 0 (0%) | 0% | 3.8 | 131,250 | Common Stock |
| V. Bryan Lawlis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 15 May 2024 | 35,000 | 35,000 (0%) | 0% | 1.9 | 67,900 | Common Stock |
| V. Bryan Lawlis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Gaurav Aggarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| John F. McDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 2,462 | 166,502 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,916 | 168,418 (0%) | 0% | 0 | Common Stock | |
| Kapur Anil | EVP, CORP STRATEGY & CCO | 14 Feb 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Samuels Alan Scott | EVP & CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 850,000 | 850,000 | - | - | Employee Stock Option (Right to Buy) | |
| Scarlett A. John | Director, CHAIRMAN, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 3,000,000 | 3,000,000 | - | - | Employee Stock Option (Right to Buy) | |
| Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 850,000 | 850,000 | - | - | Employee Stock Option (Right to Buy) | |
| J. Andrew Grethlein | EVP, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 1,200,000 | 1,200,000 | - | - | Employee Stock Option (Right to Buy) | |
| Feller Faye | EVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gaurav Aggarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 1,970 | 1,970 (0%) | 0% | 0 | Common Stock | |
| J. Spiegel Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 3,406 | 164,040 (0%) | 0% | 0 | Common Stock | |
| Susan Molineaux M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 6,220 | 130,527 (0%) | 0% | 0 | Common Stock | |
| Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 24 Aug 2023 | 6,607 | 7,407 (0%) | 0% | 2.3 | 15,064 | Common Stock |
| Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 24 Aug 2023 | 6,579 | 26,220 (0%) | 0% | 2.3 | 15,000 | Common Stock |
| Scott Alan Samuels | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 1,350,000 | 1,350,000 | - | - | Employee Stock Option (right to buy) | |
| V. Bryan Lawlis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| John F. McDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Options (right to buy) | |
| V. Bryan Lawlis | Director | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 11 May 2023 | 35,000 | 0 (0%) | 0% | 3 | 105,000 | Common Stock |
| V. Bryan Lawlis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 11 May 2023 | 35,000 | 35,000 (0%) | 0% | 1.1 | 38,500 | Common Stock |
| V. Bryan Lawlis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 35,000 | 0 | - | - | Stock Options (right to buy) | |
| Susan M. Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 01 May 2023 | 35,000 | 35,000 (0%) | 0% | 1.1 | 38,500 | Common Stock |
| Susan M. Molineaux | Director | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 01 May 2023 | 35,000 | 0 (0%) | 0% | 2.5 | 86,800 | Common Stock |
| Susan M. Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 35,000 | 0 | - | - | Stock Options (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 3,312 | 155,005 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 6,048 | 114,028 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 780,000 | 780,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 1,750,000 | 1,750,000 | - | - | Employee Stock Option (Right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 575,000 | 575,000 | - | - | Employee Stock Option (right to buy) | |
| Anil Kapur | EVP, Corp Strategy & CCO | 22 Feb 2023 | 625,000 | 625,000 | - | - | Employee Stock Option (right to buy) | ||
| Faye Feller | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 540,000 | 540,000 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 150,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 09 Feb 2023 | 234,719 | 0 (0%) | 0% | 3.0 | 711,199 | Common Stock |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 09 Feb 2023 | 150,000 | 234,719 (0%) | 0% | 3.0 | 454,500 | Common Stock |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.51 per share. | 09 Feb 2023 | 150,000 | 384,719 (0%) | 0% | 1.5 | 226,500 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 08 Feb 2023 | 446,666 | 0 (0%) | 0% | 3.0 | 1,353,398 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,666 | 446,666 (0%) | 0% | 1.5 | 669,999 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 08 Feb 2023 | 446,666 | 0 (0%) | 0% | 3.1 | 1,375,731 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,666 | 446,666 (0%) | 0% | 1.5 | 669,999 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 08 Feb 2023 | 446,668 | 446,668 (0%) | 0% | 1.5 | 670,002 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 08 Feb 2023 | 446,668 | 0 (0%) | 0% | 3 | 1,340,004 | Common Stock |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,666 | 0 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,666 | 0 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 446,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 400,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 08 Feb 2023 | 400,000 | 74,588 (0%) | 0% | 3.1 | 1,232,000 | Common Stock |
| Olivia Bloom | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.51 per share. | 08 Feb 2023 | 400,000 | 474,588 (0%) | 0% | 1.5 | 604,000 | Common Stock |
| Karin Eastham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 13 Jan 2023 | 35,000 | 109,047 (0%) | 0% | 1.1 | 38,500 | Common Stock |
| Karin Eastham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 35,000 | 0 | - | - | Stock Options (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 2,970 | 151,693 (0%) | 0% | 0 | Common Stock | |
| Anil Kapur | EVP, Corp Strategy & CCO | 30 Dec 2022 | 6,021 | 53,216 (0%) | 0% | 1.1 | 6,683 | Common Stock | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 3,071 | 148,723 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 12 Sep 2022 | 232,719 | 234,719 (0%) | 0% | 1.7 | 395,622 | Common Stock |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 12 Sep 2022 | 2,000 | 2,000 (0%) | 0% | 1.7 | 3,400 | Common Stock |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2022 | 232,719 | 0 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2022 | 2,000 | 65,281 | - | - | Employee Stock Option (right to buy) | |
| John F. McDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 200,000 | 200,000 | - | - | Stock Options (right to buy) | |
| Faye Feller | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2022 | 120,000 | 120,000 | - | - | Employee Stock Option (right to buy) | |
| Karin Eastham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2022 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Karin Eastham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 20 Apr 2022 | 35,000 | 74,047 (0%) | 0% | 1.4 | 49,350 | Common Stock |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 5,284 | 141,015 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 2,100,000 | 2,100,000 | - | - | Employee Stock Option (Right to buy) | |
| Stephen N. Rosenfield | EVP, Chief Legal Off & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Anil Kapur | EVP, Corp Strategy & CCO | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | ||
| Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 5,097 | 124,594 (0%) | 0% | 0 | Common Stock | |
| Karin Eastham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 4,549 | 119,497 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 600,000 | 600,000 | - | - | Employee Stock Option (Right to buy) | |
| Stephen N. Rosenfield | EVP, Chief Legal Off & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to buy) | |
| Melissa A. Kelly Behrs | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Anil Kapur | EVP, Corp Strategy & CCO | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | ||
| Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 4,130 | 110,428 (0%) | 0% | 0 | Common Stock | |
| Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 21 Aug 2020 | 17,441 | 19,641 (0%) | 0% | 1.7 | 30,173 | Common Stock |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 3,297 | 106,298 (0%) | 0% | 0 | Common Stock | |
| Karin Eastham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 6,039 | 103,001 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 291,375 | 291,375 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 582,750 | 582,750 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Chief Legal Off & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 291,375 | 291,375 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 291,375 | 291,375 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 291,375 | 291,375 | - | - | Employee Stock Option (right to buy) | |
| Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 291,375 | 291,375 | - | - | Employee Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 10 Jan 2020 | 800 | 800 (0%) | 0% | 1.4 | 1,080 | Common Stock |
| Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 10 Jan 2020 | 2,200 | 2,200 (0%) | 0% | 1.3 | 2,948 | Common Stock |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2019 | 5,284 | 96,962 (0%) | 0% | 0 | Common Stock | |
| Anil Kapur | EVP, Corp Strategy & CCO | 02 Dec 2019 | 700,000 | 700,000 | - | - | Employee Stock Option (right to buy) | ||
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2019 | 5,404 | 91,678 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 5,097 | 86,274 (0%) | 0% | 0 | Common Stock | |
| Karin Eastham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Srock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2019 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 09 Apr 2019 | 120,635 | 0 (0%) | 0% | 2 | 241,270 | Common Stock |
| Daniel M. Bradbury | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2019 | 9,036 | 51,323 (0%) | 0% | 0 | Commmon Stock | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2019 | 4,329 | 81,177 (0%) | 0% | 0 | Common Stock | |
| Dawn Carter Bir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2019 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2019 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 1,050,000 | 1,050,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2019 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2018 | 15,000 | 42,287 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2018 | 7,188 | 76,848 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2018 | 13,125 | 107,980 (0%) | 0% | 0 | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2018 | 8,523 | 27,287 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2018 | 4,084 | 69,660 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2018 | 7,457 | 94,855 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.29 per share. | 13 Sep 2018 | 45,000 | 110,576 (0%) | 0% | 5.3 | 238,050 | Common Stock |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 35,000 | 65,576 (0%) | 0% | 6.9 | 239,750 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 13 Sep 2018 | 35,000 | 100,576 (0%) | 0% | 1.1 | 38,500 | Common Stock |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 35,000 | 65,576 (0%) | 0% | 6.9 | 239,750 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 13 Sep 2018 | 35,000 | 100,576 (0%) | 0% | 1.4 | 49,350 | Common Stock |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 15,000 | 65,576 (0%) | 0% | 6.9 | 102,750 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.91 per share. | 13 Sep 2018 | 15,000 | 80,576 (0%) | 0% | 4.9 | 73,650 | Common Stock |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 35,000 | 65,576 (0%) | 0% | 6.9 | 239,750 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 13 Sep 2018 | 35,000 | 100,576 (0%) | 0% | 1.9 | 67,900 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 10,000 | 65,576 (0%) | 0% | 6.9 | 68,500 | Common Stock |
| Robert J. Spiegel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.91 per share. | 13 Sep 2018 | 10,000 | 75,576 (0%) | 0% | 4.9 | 49,100 | Common Stock |
| Robert J. Spiegel | None | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Sep 2018 | 45,000 | 65,576 (0%) | 0% | 6.9 | 308,250 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 200,000 | 0 (0%) | 0% | 4.5 | 902,000 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 36,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 425,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 420,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 131,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 112,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2018 | 37,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 24 Aug 2018 | 36,000 | 36,000 (0%) | 0% | 2.2 | 79,920 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 36,000 | 0 (0%) | 0% | 4.5 | 162,360 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 24 Aug 2018 | 425,000 | 425,000 (0%) | 0% | 2.1 | 909,500 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 425,000 | 0 (0%) | 0% | 4.5 | 1,916,750 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 24 Aug 2018 | 200,000 | 200,000 (0%) | 0% | 1.4 | 282,000 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.51 per share. | 24 Aug 2018 | 420,000 | 420,000 (0%) | 0% | 1.5 | 634,200 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 420,000 | 0 (0%) | 0% | 4.5 | 1,894,200 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 24 Aug 2018 | 131,250 | 131,250 (0%) | 0% | 2.5 | 333,375 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 131,250 | 0 (0%) | 0% | 4.5 | 591,938 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.15 per share. | 24 Aug 2018 | 112,500 | 112,500 (0%) | 0% | 2.2 | 241,875 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 112,500 | 0 (0%) | 0% | 4.5 | 507,375 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 24 Aug 2018 | 37,500 | 37,500 (0%) | 0% | 2.5 | 91,875 | Common Stock |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 24 Aug 2018 | 37,500 | 0 (0%) | 0% | 4.5 | 169,125 | Common Stock |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 4,373 | 18,764 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 2,095 | 65,576 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2018 | 3,827 | 87,398 (0%) | 0% | 0 | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2018 | 3,529 | 14,391 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2018 | 1,691 | 63,481 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2018 | 3,088 | 83,571 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 1,050,000 | 1,050,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP Portfolio & Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 350,000 | 350,000 | - | - | Employee Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2017 | 10,764 | 154,301 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2017 | 3,993 | 61,790 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2017 | 7,292 | 80,483 (0%) | 0% | 0 | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2017 | 8,888 | 143,537 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2017 | 3,297 | 57,797 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2017 | 6,021 | 73,191 (0%) | 0% | 0 | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 6,995 | 134,649 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 2,595 | 54,500 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 4,738 | 67,170 (0%) | 0% | 0 | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2017 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 8,535 | 127,654 (0%) | 0% | 0 | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 3,166 | 51,905 (0%) | 0% | 0 | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2017 | 5,782 | 62,432 (0%) | 0% | 0 | Common Stock | |
| Andrew J. Grethlein | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 1,050,000 | 1,050,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP BD, Port & Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2016 | 6,341 | 56,650 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2016 | 5,808 | 50,309 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2016 | 4,897 | 44,501 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2016 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2016 | 4,495 | 39,604 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | EVP, BD, Port & Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2016 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2016 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2016 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Development &Tech Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2016 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2016 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2015 | 2,712 | 35,109 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2015 | 4,755 | 32,397 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2015 | 3,067 | 27,642 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | EVP BD and Port&Alliance Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 May 2015 | 2,380 | 120,635 | - | - | Common Stock | |
| Olivia Bloom | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 May 2015 | 2,380 | 74,588 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2015 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2015 | 3,481 | 24,575 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 35,000 | 96,564 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Thomas Hofstaetter | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2015 | 70,000 | 26,564 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 35,000 | 61,564 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP BD and Port&Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Tech Ops and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2014 | 5,577 | 39,047 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2014 | 2,212 | 48,739 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2014 | 4,038 | 21,094 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2014 | 4,283 | 10,862 | - | - | Common Stock | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2014 | 5,646 | 35,970 | - | - | Common Stock | |
| Karin Eastham | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 2,500 | 33,470 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | EVP Portfolio & Alliance Mgmt | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 20,000 | 123,015 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 2,500 | 26,564 | - | - | Common Stock | |
| Hoyoung Huh | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 10,000 | 119,119 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2014 | 4,478 | 49,027 | - | - | Common Stock | |
| Robert J. Spiegel | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 2,500 | 46,527 | - | - | Common Stock | |
| Olivia Bloom | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2014 | 5,000 | 76,968 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2014 | 4,089 | 17,056 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | EVP Portfolio & Alliance Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 May 2014 | 4,826 | 143,015 | - | - | Common Stock | |
| Olivia Bloom | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 May 2014 | 3,379 | 81,968 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2014 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Daniel M. Bradbury | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 May 2014 | 142,776 | 142,776 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | EVP Portfolio & Alliance Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2014 | 12,310 | 147,841 | - | - | Common Stock | |
| Olivia Bloom | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2014 | 7,435 | 85,347 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2014 | 6,579 | 6,579 | - | - | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2014 | 9,270 | 129,119 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2014 | 6,878 | 44,549 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2014 | 6,280 | 12,967 | - | - | Common Stock | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2014 | 1,340,000 | 1,340,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | EVP Portfolio & Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2014 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2014 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2014 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2014 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Craig C. Parker | EVP, Corp Dev & Sci Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2014 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 3,824 | 30,324 | - | - | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 4,088 | 119,849 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 3,033 | 37,671 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2013 | 2,769 | 6,687 | - | - | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2013 | 5,784 | 115,761 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2013 | 4,291 | 34,638 | - | - | Common Stock | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2013 | 3,918 | 3,918 | - | - | Common Stock | |
| Karin Eastham | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 45,000 | 26,500 | - | - | Common Stock | |
| Melissa A. Kelly Behrs | SVP Portfolio & Alliance Mgmt | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 225,000 | 160,151 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 45,000 | 29,064 | - | - | Common Stock | |
| Hoyoung Huh | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 45,000 | 109,977 | - | - | Common Stock | |
| Robert J. Spiegel | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 45,000 | 30,347 | - | - | Common Stock | |
| Robert J. Spiegel | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 45,000 | 30,347 | - | - | Common Stock | |
| Olivia Bloom | SVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2013 | 50,000 | 92,782 | - | - | Common Stock | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2013 | 12,450 | 154,977 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2013 | 4,792 | 75,347 | - | - | Common Stock | |
| Edward V. Fritzky | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 May 2013 | 53,812 | 186,511 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Thomas D. Kiley | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 May 2013 | 53,156 | 171,911 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2013 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Stephen M. Kelsey | EVP, R&D, Chief Med Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2013 | 386,875 | 62,272 | - | - | Common Stock | |
| John A. Scarlett | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Apr 2013 | 50,000 | 125,000 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 15,187 | 240,323 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 6,717 | 70,555 | - | - | Common Stock | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2013 | 1,340,000 | 1,340,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | SVP Portfolio & Alliance Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 420,000 | 420,000 | - | - | Employee Stock Option (right to buy) | |
| Andrew J. Grethlein | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen M. Kelsey | EVP, R&D, Chief Med Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 470,000 | 470,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Craig C. Parker | SVP, Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2013 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly Behrs | SVP Alliance and Prog Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Jan 2013 | 28,292 | 0 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2012 | 11,525 | 227,636 | - | - | Common Stock | |
| Edward V. Fritzky | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 2,500 | 225,136 | - | - | Common Stock | |
| Karin Eastham | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 2,500 | 71,500 | - | - | Common Stock | |
| Melissa A. Kelly | Director, SVP Portfolio & Alliance Mgmt | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 20,000 | 385,151 | - | - | Common Stock | |
| Thomas D. Kiley | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 2,500 | 225,067 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 2,500 | 74,064 | - | - | Common Stock | |
| Hoyoung Huh | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 10,000 | 142,527 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 40,000 | 449,147 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2012 | 5,098 | 66,338 | - | - | Common Stock | |
| Robert J. Spiegel | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 2,500 | 63,838 | - | - | Common Stock | |
| Olivia Bloom | SVP, CFO and Treasurer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2012 | 5,000 | 142,782 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2012 | 9,503 | 216,111 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2012 | 4,203 | 61,240 | - | - | Common Stock | |
| Daniel M. Bradbury | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2012 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Susan M. Molineaux | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2012 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| David J. Earp | SVP, Corp Transactions | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2012 | 27,155 | 467,406 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 May 2012 | 18,910 | 405,151 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 May 2012 | 9,300 | 473,122 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 May 2012 | 11,029 | 147,782 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 13,150 | 206,608 | - | - | Common Stock | |
| V. Bryan Lawlis | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 505,000 | 505,000 | - | - | Employee Stock Option (right to buy) | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 14,923 | 76,564 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Graham K. Cooper | EVP, Bus Dev & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 21,277 | 152,527 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2012 | 215,000 | 215,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen N. Rosenfield | EVP, Genl Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2012 | 425,000 | 425,000 | - | - | Employee Stock Option (right to buy) | |
| John A. Scarlett | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2012 | 75,000 | 75,000 | - | - | Common Stock | |
| Graham K. Cooper | EVP, Bus Dev & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2012 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2011 | 2,716 | 482,422 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2011 | 2,933 | 479,706 | - | - | Common Stock | |
| Thomas D. Kiley | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2011 | 64,275 | 314,059 | - | - | Common Stock | |
| Thomas D. Kiley | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Oct 2011 | 50,000 | 96,653 | - | - | Common Stock | |
| David J. Earp | Chief Legal Counsel | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 25,262 | 494,561 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 34,005 | 754,031 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 25,262 | 568,154 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 25,262 | 424,061 | - | - | Common Stock | |
| Katharine E. Spink | SVP Alliance Mgmt & Operations | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 22,591 | 328,561 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 4,858 | 476,773 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2011 | 6,997 | 158,811 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 190,958 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 193,458 | - | - | Common Stock | |
| Alexander E. Barkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 348,122 | - | - | Common Stock | |
| Alexander E. Barkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 353,122 | - | - | Common Stock | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 74,000 | - | - | Common Stock | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 71,500 | - | - | Common Stock | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 25,000 | 453,298 | - | - | Common Stock | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 59,500 | 512,798 | - | - | Common Stock | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 2,975 | 519,823 | - | - | Common Stock | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 522,798 | - | - | Common Stock | |
| David J. Earp | SVP Bus Dev, Chief Patnt Couns | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 517,798 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 674,998 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 77,500 | 752,498 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 20,000 | 792,498 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 20,000 | 772,498 | - | - | Common Stock | |
| David L. Greenwood | Director, President, Interim CEO, CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 4,462 | 788,036 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 64,500 | 586,391 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 2,975 | 593,416 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 596,391 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 25,000 | 521,891 | - | - | Common Stock | |
| Jane S. Lebkowski | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 591,391 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 20,000 | 452,298 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 20,000 | 432,298 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 26,250 | 412,298 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 2,975 | 449,323 | - | - | Common Stock | |
| Melissa A. Kelly | SVP Strategic Portfolio Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 25,000 | 386,048 | - | - | Common Stock | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 225,067 | - | - | Common Stock | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 227,567 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 59,141 | - | - | Common Stock | |
| Thomas Hofstaetter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 61,641 | - | - | Common Stock | |
| Hoyoung Huh | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 28,750 | 111,250 | - | - | Common Stock | |
| Hoyoung Huh | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 15,000 | 15,000 | - | - | Employee Stock Option (right to buy) | |
| Hoyoung Huh | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 121,250 | - | - | Common Stock | |
| Hoyoung Huh | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 57,500 | 57,500 | - | - | Employee Stock Option (right to buy) | |
| Hoyoung Huh | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 131,250 | - | - | Common Stock | |
| Katharine E. Spink | SVP Prgm Mgmt, Cell Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 25,000 | 341,571 | - | - | Common Stock | |
| Katharine E. Spink | SVP Prgm Mgmt, Cell Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Katharine E. Spink | SVP Prgm Mgmt, Cell Therapies | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 419 | 351,152 | - | - | Common Stock | |
| Katharine E. Spink | SVP Prgm Mgmt, Cell Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 351,571 | - | - | Common Stock | |
| Katharine E. Spink | SVP Prgm Mgmt, Cell Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 346,571 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 37,500 | 401,631 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 40,000 | 441,631 | - | - | Common Stock | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Stephen M. Kelsey | EVP, R&D Head, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 40,000 | 481,631 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 54,537 | - | - | Common Stock | |
| Robert J. Spiegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 2,500 | 57,037 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 16,000 | 107,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 137,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 20,000 | 157,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 117,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 127,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 25,000 | 91,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2011 | 1,200 | 165,808 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 167,008 | - | - | Common Stock | |
| Olivia Bloom | VP, Chief Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 162,008 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 40,000 | 65,000 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 60,000 | 125,000 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 10,000 | 25,000 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 190,000 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 60,000 | 185,000 | - | - | Common Stock | |
| Melanie I. Nallicheri | SVP Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 5,000 | 195,000 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 2,500 | 180,958 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 7,000 | 178,458 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 4,073 | 171,458 | - | - | Common Stock | |
| Edward V. Fritzky | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 7,500 | 188,458 | - | - | Common Stock | |
| Alexander E. Barkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 5,000 | 343,122 | - | - | Common Stock | |
| Alexander E. Barkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 14,000 | 338,122 | - | - | Common Stock | |
| Alexander E. Barkas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 9,000 | 69,000 | - | - | Common Stock | |
| Karin Eastham | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 4,073 | 206,567 | - | - | Common Stock | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 7,500 | 222,567 | - | - | Common Stock | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 2,500 | 215,067 | - | - | Common Stock | |
| Thomas D. Kiley | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 6,000 | 212,567 | - | - | Common Stock | |
| Charles J. Homcy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2011 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Charles J. Homcy | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 May 2011 | 57,500 | 62,751 | - | - | Common Stock |